Evidence map›Paper›PMID 31234489›Full record

ArticleAntioxidants (Basel, Switzerland)2019

Paraoxonase 1, HDL Subclasses and Post Surgery Acute Inflammation: A Pilot Study.

Yasmin Bains, Russell Caccavello, Kazuhiko Kotani, Alejandro Gugliucci

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. CRP/HDL-C and Monocyte/HDL-C ratios as Predictors of Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus.Acta informatica medica : AIM : journal of the Society for Medical Informatics of Bosnia & Herzegovina : casopis Drustva za medicinsku informatiku BiH · 2023
    Article
  9. Article
  10. Review
  11. Revealing the Role of High-Density Lipoprotein in Colorectal Cancer.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Yasmin BainsGlycation, Oxidation and Disease Lab, Research Department, Touro California College of Osteopathic Medicine, Vallejo, CA 94592, USA. Yasmin.bains@tu.edu.
Russell CaccavelloGlycation, Oxidation and Disease Lab, Research Department, Touro California College of Osteopathic Medicine, Vallejo, CA 94592, USA. russell.caccavello@tu.edu.
Kazuhiko KotaniGlycation, Oxidation and Disease Lab, Research Department, Touro California College of Osteopathic Medicine, Vallejo, CA 94592, USA. kazukotani@jichi.ac.jp.
Alejandro GugliucciGlycation, Oxidation and Disease Lab, Research Department, Touro California College of Osteopathic Medicine, Vallejo, CA 94592, USA. alejandro.gugliucci@tu.edu.
Touro University California · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High density lipoproteins (HDL) structure and function studies are needed to better understand the heterogeneous nature of the HDL particle, and its interaction with associated proteins such as apolipoprotein A-1 (ApoA-1), paraoxonase 1 (PON1) and the environment. Our study assesses the effects of acute inflammation on PON1 and HDL subclasses in post-surgical colorectal cancer patients. PON1 was measured kinetically through its arylesterase and lactonase activity and HDL sub-classes were measured using Quantimetrix Lipoprint

Indexed as

Acute inflammationApoA-1Chronic InflammationColorectal CancerCRPHDL subclassesPON1SAA

Identifiers

PMID31234489
PMCPMC6617233
OpenAlexW2950562964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.